Dexcom is in talks to acquire device firm Insulet
The US-based company behind glucose-monitoring systems could become a giant on the diabetes device market following a rumored acquisition of Insulet, a maker of insulin pumps.
By Ed Hammond and Michelle F. Davis, bloomberg
Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in diabetes devices, according to people with knowledge of the matter. Insulet rose as much as 16% in after-market trading on the news.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma sells insulin pump to Mannkind Corporation
For subscribers
.jpg)
Zealand Pharma stock soars after selling insulin pump
For subscribers
.jpg&w=384&q=75)
